Business Description
S Biomedics Co Ltd
ISIN : KR7304360001
Compare
Compare
Traded in other countries / regions
304360.Korea IPO Date
2023-05-04Description
S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.21 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.09 | |||||
| Debt-to-EBITDA | -3.16 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.09 | |||||
| Beneish M-Score | -2.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 31.6 | |||||
| 3-Year EBITDA Growth Rate | 18.8 | |||||
| 3-Year EPS without NRI Growth Rate | 3.4 | |||||
| 3-Year FCF Growth Rate | -9.5 | |||||
| 3-Year Book Growth Rate | 2.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.99 | |||||
| 9-Day RSI | 32.47 | |||||
| 14-Day RSI | 34.78 | |||||
| 3-1 Month Momentum % | -14.52 | |||||
| 6-1 Month Momentum % | -39.91 | |||||
| 12-1 Month Momentum % | 233.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.29 | |||||
| Cash Ratio | 2 | |||||
| Days Inventory | 157.32 | |||||
| Days Sales Outstanding | 42.6 | |||||
| Days Payable | 17.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | -3.08 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.01 | |||||
| Operating Margin % | -44.72 | |||||
| Net Margin % | -50.97 | |||||
| FCF Margin % | -38.64 | |||||
| ROE % | -99.23 | |||||
| ROA % | -20.52 | |||||
| ROIC % | -24.19 | |||||
| 3-Year ROIIC % | 16.91 | |||||
| ROC (Joel Greenblatt) % | -90.73 | |||||
| ROCE % | -21.86 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 14.93 | |||||
| PB Ratio | 19.28 | |||||
| Price-to-Tangible-Book | 19.42 | |||||
| EV-to-EBIT | -37.65 | |||||
| EV-to-EBITDA | -55.14 | |||||
| EV-to-Revenue | 15.29 | |||||
| EV-to-FCF | -39.57 | |||||
| Earnings Yield (Greenblatt) % | -2.66 | |||||
| FCF Yield % | -2.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
S Biomedics Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 13,022.634 | ||
| EPS (TTM) (â‚©) | -573 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 206.08 | ||
| 14-Day RSI | 34.78 | ||
| 14-Day ATR (â‚©) | 2114.786301 | ||
| 20-Day SMA (â‚©) | 19615 | ||
| 12-1 Month Momentum % | 233.75 | ||
| 52-Week Range (â‚©) | 7800 - 51600 | ||
| Shares Outstanding (Mil) | 11.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
S Biomedics Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
S Biomedics Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
S Biomedics Co Ltd Frequently Asked Questions
What is S Biomedics Co Ltd(XKRX:304360)'s stock price today?
The current price of XKRX:304360 is â‚©17130.00. The 52 week high of XKRX:304360 is â‚©51600.00 and 52 week low is â‚©7800.00.
When is next earnings date of S Biomedics Co Ltd(XKRX:304360)?
The next earnings date of S Biomedics Co Ltd(XKRX:304360) is .
Does S Biomedics Co Ltd(XKRX:304360) pay dividends? If so, how much?
S Biomedics Co Ltd(XKRX:304360) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers